218 related articles for article (PubMed ID: 19277603)
1. Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy.
Yang SJ; IglayReger HB; Kadouh HC; Bodary PF
Diabetologia; 2009 May; 52(5):972-81. PubMed ID: 19277603
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice.
Nio Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Funata M; Yamaguchi M; Ueki K; Kadowaki T
Diabetologia; 2012 Dec; 55(12):3350-8. PubMed ID: 22983634
[TBL] [Abstract][Full Text] [Related]
3. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
4. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes.
Ebihara K; Ogawa Y; Masuzaki H; Shintani M; Miyanaga F; Aizawa-Abe M; Hayashi T; Hosoda K; Inoue G; Yoshimasa Y; Gavrilova O; Reitman ML; Nakao K
Diabetes; 2001 Jun; 50(6):1440-8. PubMed ID: 11375346
[TBL] [Abstract][Full Text] [Related]
5. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
[TBL] [Abstract][Full Text] [Related]
6. C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model.
Kim HM; Lee ES; Lee BR; Yadav D; Kim YM; Ko HJ; Park KS; Lee EY; Chung CH
PLoS One; 2015; 10(3):e0120711. PubMed ID: 25816097
[TBL] [Abstract][Full Text] [Related]
7. An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice.
Tateya S; Tamori Y; Kawaguchi T; Kanda H; Kasuga M
Endocrinology; 2010 Mar; 151(3):971-9. PubMed ID: 20056828
[TBL] [Abstract][Full Text] [Related]
8. C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.
Tamura Y; Sugimoto M; Murayama T; Minami M; Nishikaze Y; Ariyasu H; Akamizu T; Kita T; Yokode M; Arai H
J Atheroscler Thromb; 2010 Mar; 17(3):219-28. PubMed ID: 20179360
[TBL] [Abstract][Full Text] [Related]
9. CCR2 modulates inflammatory and metabolic effects of high-fat feeding.
Weisberg SP; Hunter D; Huber R; Lemieux J; Slaymaker S; Vaddi K; Charo I; Leibel RL; Ferrante AW
J Clin Invest; 2006 Jan; 116(1):115-24. PubMed ID: 16341265
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice.
Tamura Y; Sugimoto M; Murayama T; Ueda Y; Kanamori H; Ono K; Ariyasu H; Akamizu T; Kita T; Yokode M; Arai H
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2195-201. PubMed ID: 18818420
[TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
Parker R; Weston CJ; Miao Z; Corbett C; Armstrong MJ; Ertl L; Ebsworth K; Walters MJ; Baumart T; Newland D; McMahon J; Zhang P; Singh R; Campbell J; Newsome PN; Charo I; Schall TJ; Adams DH
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G483-G493. PubMed ID: 29420066
[TBL] [Abstract][Full Text] [Related]
12. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.
Gavrilova O; Marcus-Samuels B; Graham D; Kim JK; Shulman GI; Castle AL; Vinson C; Eckhaus M; Reitman ML
J Clin Invest; 2000 Feb; 105(3):271-8. PubMed ID: 10675352
[TBL] [Abstract][Full Text] [Related]
13. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.
Obstfeld AE; Sugaru E; Thearle M; Francisco AM; Gayet C; Ginsberg HN; Ables EV; Ferrante AW
Diabetes; 2010 Apr; 59(4):916-25. PubMed ID: 20103702
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CCL2/CCR2 Signaling Pathway Exerts Anti-Inflammatory Effects and Attenuates Gestational Diabetes Mellitus in a Genetic Mice Model.
Qi X; Xing Y; Wang X
Horm Metab Res; 2021 Jan; 53(1):56-62. PubMed ID: 33022739
[TBL] [Abstract][Full Text] [Related]
16. CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice.
Kang YS; Lee MH; Song HK; Ko GJ; Kwon OS; Lim TK; Kim SH; Han SY; Han KH; Lee JE; Han JY; Kim HK; Cha DR
Kidney Int; 2010 Nov; 78(9):883-94. PubMed ID: 20686445
[TBL] [Abstract][Full Text] [Related]
17. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2.
Miura K; Yang L; van Rooijen N; Ohnishi H; Seki E
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1310-21. PubMed ID: 22442158
[TBL] [Abstract][Full Text] [Related]
18. Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization.
Ryu S; Liu X; Guo T; Guo Z; Zhang J; Cao YQ
Brain; 2023 Oct; 146(10):4274-4291. PubMed ID: 37284790
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2.
Stahl EC; Delgado ER; Alencastro F; LoPresti ST; Wilkinson PD; Roy N; Haschak MJ; Skillen CD; Monga SP; Duncan AW; Brown BN
Am J Pathol; 2020 Feb; 190(2):372-387. PubMed ID: 31843499
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance.
Colombo C; Haluzik M; Cutson JJ; Dietz KR; Marcus-Samuels B; Vinson C; Gavrilova O; Reitman ML
J Biol Chem; 2003 Feb; 278(6):3992-9. PubMed ID: 12456680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
